• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (207)   Subscriber (50363)
For: Cohen SY. ANTI-VEGF DRUGS AS THE 2009 FIRST-LINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA. Retina 2009;29:1062-6. [DOI: 10.1097/iae.0b013e3181b1bb1a] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Number Cited by Other Article(s)
51
MULTIFOCAL ELECTRORETINOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY CHANGES AFTER REPEATED INTRAVITREAL BEVACIZUMAB (AVASTIN) IN MYOPIC CHOROIDAL NEOVASCULARIZATION. Retina 2013;33:598-605. [DOI: 10.1097/iae.0b013e3182681066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
52
Tufail A, Patel PJ, Sivaprasad S, Amoaku W, Browning AC, Cole M, Gale R, George S, Lotery AJ, Majid M, McKibbin M, Menon G, Yang Y, Andrews C, Brittain C, Osborne A. Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study. Eye (Lond) 2013;27:709-15. [PMID: 23449508 DOI: 10.1038/eye.2013.8] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]  Open
53
Milani P, Massacesi A, Setaccioli M, Moschini S, Mantovani E, Ciaccia S, Bergamini F. Sensitivity of fluorescein angiography alone or with SD-OCT for the diagnosis of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2013;251:1891-900. [PMID: 23436079 DOI: 10.1007/s00417-013-2282-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2012] [Revised: 01/17/2013] [Accepted: 01/29/2013] [Indexed: 11/25/2022]  Open
54
De Bats F, Grange JD, Denis P, Kodjikian L. Néovaisseaux choroïdiens du myope fort naïfs traités par injections intravitréennes de bévacizumab : résultats à plus de 12 mois. J Fr Ophtalmol 2013;36:12-8. [DOI: 10.1016/j.jfo.2012.04.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2011] [Revised: 03/31/2012] [Accepted: 04/10/2012] [Indexed: 11/28/2022]
55
Oh HN, Lee JE, Kim HW, Yun IH. Predictive Factors for Visual Outcome after Treatment for Myopic Choroidal Neovascularization. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY 2013. [DOI: 10.3341/jkos.2013.54.4.610] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
56
Anti–Vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularization. Retina 2012;32:1443-5. [DOI: 10.1097/iae.0b013e31826956e4] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
57
Effectiveness of 1.25 % povidone–iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection. Jpn J Ophthalmol 2012;56:497-501. [DOI: 10.1007/s10384-012-0160-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2011] [Accepted: 05/08/2012] [Indexed: 10/28/2022]
58
Introini U, Casalino G, Cardani A, Scotti F, Finardi A, Candiani M, Bandello F. Intravitreal bevacizumab for a subfoveal myopic choroidal neovascularization in the first trimester of pregnancy. J Ocul Pharmacol Ther 2012;28:553-5. [PMID: 22662749 DOI: 10.1089/jop.2012.0067] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
59
Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization. Eye (Lond) 2012;26:1004-11. [PMID: 22595908 DOI: 10.1038/eye.2012.97] [Citation(s) in RCA: 75] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]  Open
60
Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet 2012;379:1739-48. [PMID: 22559900 DOI: 10.1016/s0140-6736(12)60272-4] [Citation(s) in RCA: 1172] [Impact Index Per Article: 97.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
61
PROGNOSTIC FACTORS FOR VISUAL OUTCOME AFTER INTRAVITREAL ANTI-VEGF INJECTION FOR NAIVE MYOPIC CHOROIDAL NEOVASCULARIZATION. Retina 2012. [DOI: 10.1097/iae.0b013e318227aa09] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
62
Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M, Laurent M, Astier A. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration. ANNALES PHARMACEUTIQUES FRANÇAISES 2012;70:139-54. [DOI: 10.1016/j.pharma.2012.03.006] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Revised: 03/29/2012] [Accepted: 03/29/2012] [Indexed: 11/16/2022]
63
Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization. Eye (Lond) 2012;26:976-82. [PMID: 22538218 DOI: 10.1038/eye.2012.75] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]  Open
64
Ng DS, Kwok AKH, Chan CW. Anti-vascular endothelial growth factor for myopic choroidal neovascularization. Clin Exp Ophthalmol 2012;40:e98-e110. [PMID: 21902785 DOI: 10.1111/j.1442-9071.2011.02684.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
65
Predictive factors for visual outcome to intravitreal bevacizumab in young Chinese patients with myopic choroidal neovascularization. Retina 2012;31:1835-40. [PMID: 21878845 DOI: 10.1097/iae.0b013e31821ba2dc] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
66
Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, Perri P, D'Angelo S, Romano MR, De Nadai K, Sebastiani A, Incorvaia C. Genetic predictors of response to photodynamictherapy. Mol Diagn Ther 2012;15:195-210. [PMID: 21913742 DOI: 10.1007/bf03256411] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
67
Dethorey G, Leveziel N, Lalloum F, Forte R, Guigui B, Querques G, Glacet-Bernard A, Soubrane G, Souied H. Comparaison du traitement par injections intravitréennes de ranibizumab à la photothérapie dynamique dans la néovascularisation choroïdienne compliquant la myopie forte. J Fr Ophtalmol 2012;35:106-12. [DOI: 10.1016/j.jfo.2011.03.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2011] [Revised: 03/21/2011] [Accepted: 03/21/2011] [Indexed: 11/16/2022]
68
Recent trends in the management of maculopathy secondary to pathological myopia. Graefes Arch Clin Exp Ophthalmol 2011;250:3-13. [DOI: 10.1007/s00417-011-1889-0] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2011] [Revised: 08/30/2011] [Accepted: 09/06/2011] [Indexed: 10/14/2022]  Open
69
Wu TT, Kung YH. The 12-month outcome of three consecutive monthly intravitreal injections of ranibizumab for myopic choroidal neovascularization. J Ocul Pharmacol Ther 2011;28:129-33. [PMID: 22066662 DOI: 10.1089/jop.2011.0106] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
70
Photothérapie dynamique sous huile de silicone pour traiter des néovaisseaux choroïdiens du myope fort. J Fr Ophtalmol 2011;34:561.e1-4. [DOI: 10.1016/j.jfo.2011.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2010] [Accepted: 12/25/2010] [Indexed: 11/20/2022]
71
Creuzot-Garcher C. Innovations thérapeutiques dans les pathologies vasculaires et néovasculaires hors DMLA. J Fr Ophtalmol 2011;34:502-7. [DOI: 10.1016/j.jfo.2011.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2010] [Accepted: 04/11/2011] [Indexed: 10/18/2022]
72
Karagiannis D, Soumplis V, Georgalas I, Kandarakis A. Ranibizumab for idiopathic retinal vasculitis, aneurysms, and neuroretinitis: favorable results. Eur J Ophthalmol 2011;20:792-4. [PMID: 20099231 DOI: 10.1177/112067211002000425] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
73
Park JY, Kim SH, Park TK, Ohn YH. Multifocal electroretinogram findings after intravitreal bevacizumab injection in choroidal neovascularization of age-related macular degeneration. KOREAN JOURNAL OF OPHTHALMOLOGY 2011;25:161-5. [PMID: 21655040 PMCID: PMC3102818 DOI: 10.3341/kjo.2011.25.3.161] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2010] [Accepted: 10/02/2010] [Indexed: 11/23/2022]  Open
74
Perol J, Wolff B, Sahel JA, Le Mer Y. Traitement par injection intravitréenne de bevacizumab de néovaisseaux choroïdiens compliquant une maladie de Best. J Fr Ophtalmol 2011;34:281-6. [DOI: 10.1016/j.jfo.2010.11.021] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2010] [Revised: 11/03/2010] [Accepted: 11/20/2010] [Indexed: 11/29/2022]
75
Liu J, Jha P, Lyzogubov VV, Tytarenko RG, Bora NS, Bora PS. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem 2011;286:20991-1001. [PMID: 21515678 DOI: 10.1074/jbc.m111.226266] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]  Open
76
The role of intravitreal bevacizumab in experimental posterior penetrating eye injury. Retina 2011;31:154-60. [PMID: 20838359 DOI: 10.1097/iae.0b013e3181e096f3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
77
Xu CT, Li SQ, Lü YG, Pan BR. Development of biomedical publications on ametropia research in PubMed from 1845 to 2010: a bibliometric analysis. Int J Ophthalmol 2011;4:1-7. [PMID: 22553598 DOI: 10.3980/j.issn.2222-3959.2011.01.01] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2010] [Accepted: 01/15/2011] [Indexed: 01/26/2023]  Open
78
Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization. Eye (Lond) 2011;25:375-81. [PMID: 21252956 DOI: 10.1038/eye.2010.226] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]  Open
79
Lorenzo D, Arias L, Alcubierre R, Pujol O, Caminal J, Rubio M, Català J, Garcia-Bru P, Arruga J. Intravitreal Ranibizumab for Choroidal Neovascularization Secondary to Pathological Myopia: 12-Month Follow-Up. Ophthalmologica 2011;226:103-9. [DOI: 10.1159/000328980] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2011] [Accepted: 04/21/2011] [Indexed: 12/29/2022]
80
Besozzi G, Sborgia L, Furino C, Cardascia N, Dammacco R, Sborgia G, Modoni AP, Boscia F. Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety. Graefes Arch Clin Exp Ophthalmol 2009;248:497-502. [PMID: 19916015 DOI: 10.1007/s00417-009-1232-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2009] [Revised: 10/20/2009] [Accepted: 10/22/2009] [Indexed: 10/20/2022]  Open
PrevPage 2 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA